Patterns and rates of exonic de novo mutations in autism spectrum disorders.
Benjamin M. Neale
(1, 2)
,
Yan Kou
(3, 4)
,
Li Liu
(5)
,
Avi Ma'Ayan
(3)
,
Kaitlin E Samocha
(2, 1)
,
Aniko Sabo
(6)
,
Chiao-Feng Lin
(7)
,
Christine Stevens
(2)
,
Li-San Wang
(7)
,
Vladimir Makarov
(4, 8)
,
Paz Polak
(2, 9)
,
Seungtai Yoon
(4, 8)
,
Jared Maguire
(2)
,
Emily L. Crawford
(10)
,
Nicholas G. Campbell
(10)
,
Evan T. Geller
(7)
,
Otto Valladares
(7)
,
Chad Schafer
(5)
,
Han Liu
(11)
,
Tuo Zhao
(11)
,
Guiqing Cai
(4, 8)
,
Jayon Lihm
(4, 8)
,
Ruth Dannenfelser
(3)
,
Omar Jabado
(12)
,
Zuleyma Peralta
(12)
,
Uma Nagaswamy
(6)
,
Donna Muzny
(6)
,
Jeffrey G. Reid
(6)
,
Irene Newsham
(6)
,
Yuanqing Wu
(6)
,
Lora Lewis
(6)
,
Yi Han
(6)
,
Benjamin F. Voight
(2, 13)
,
Elaine Lim
(1, 2)
,
Elizabeth Rossin
(1, 2)
,
Andrew Kirby
(1, 2)
,
Jason Flannick
(2)
,
Menachem Fromer
(1, 2)
,
Khalid Shakir
(2)
,
Tim Fennell
(2)
,
Kiran Garimella
(2)
,
Eric Banks
(2)
,
Ryan Poplin
(2)
,
Stacey Gabriel
(2)
,
Mark Depristo
(2)
,
Jack R. Wimbish
(14)
,
Braden E. Boone
(14)
,
Shawn E. Levy
(14)
,
Catalina Betancur
(15)
,
Shamil Sunyaev
(2, 9)
,
Eric Boerwinkle
(6, 16)
,
Joseph D. Buxbaum
(4, 8, 12, 17)
,
Edwin H. Cook
(18)
,
Bernie Devlin
(19)
,
Richard A. Gibbs
(6)
,
Kathryn Roeder
(5)
,
Gerard D. Schellenberg
(7)
,
James S. Sutcliffe
(10)
,
Mark J. Daly
(1, 2)
1
Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School
2 Program in Medical and Population Genetics, Broad Institute of Harvard and MIT
3 Department of pharmacology and systems therapeutics [Mount Sinai]
4 Seaver Autism Center for Research and Treatment
5 Department of Statistics, Carnegie Mellon University
6 Human Genome Sequencing Center, Baylor College of Medicine
7 Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania
8 Department of Psychiatry
9 Division of Genetics
10 Department of Molecular Physiology & Biophysics and Psychiatry
11 Biostatistics Department and Computer Science Department, Johns Hopkins University
12 Departments of Psychiatry, Genetics and Genomic Sciences
13 Department of Pharmacology
14 HudsonAlpha Institute for Biotechnology [Huntsville, AL]
15 Physiopathologie des Maladies du Système Nerveux Central
16 Human Genetics Center
17 Friedman Brain Institute
18 Department of Psychiatry
19 Department of Psychiatry [Pittsburgh]
2 Program in Medical and Population Genetics, Broad Institute of Harvard and MIT
3 Department of pharmacology and systems therapeutics [Mount Sinai]
4 Seaver Autism Center for Research and Treatment
5 Department of Statistics, Carnegie Mellon University
6 Human Genome Sequencing Center, Baylor College of Medicine
7 Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania
8 Department of Psychiatry
9 Division of Genetics
10 Department of Molecular Physiology & Biophysics and Psychiatry
11 Biostatistics Department and Computer Science Department, Johns Hopkins University
12 Departments of Psychiatry, Genetics and Genomic Sciences
13 Department of Pharmacology
14 HudsonAlpha Institute for Biotechnology [Huntsville, AL]
15 Physiopathologie des Maladies du Système Nerveux Central
16 Human Genetics Center
17 Friedman Brain Institute
18 Department of Psychiatry
19 Department of Psychiatry [Pittsburgh]
Catalina Betancur
- Function : Author
- PersonId : 13320
- IdHAL : catalina-betancur
- ORCID : 0000-0002-3327-4804
- IdRef : 180835750
Joseph D. Buxbaum
Connectez-vous pour contacter l'auteur
- Function : Correspondent author
- PersonId : 859551
Connectez-vous pour contacter l'auteur
Kathryn Roeder
Connectez-vous pour contacter l'auteur
- Function : Correspondent author
- PersonId : 951838
Connectez-vous pour contacter l'auteur
Mark J. Daly
Connectez-vous pour contacter l'auteur
- Function : Correspondent author
- PersonId : 951919
Connectez-vous pour contacter l'auteur
Abstract
Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case-control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.
Domains
Genetics
Fichier principal
Neale-main_text.pdf (566.88 Ko)
Télécharger le fichier
Neale-Supplementary_information.pdf (852.08 Ko)
Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Loading...